Stocks Hitting 52-Week Highs

Durata Therapeutics DRTX shares reached a new 52-week high of $23.66 after Actavis ACT announced its plans to buy Durata Therapeutics for around $616.4 million. Chimerix CMRX shares jumped 8.84% to touch a new 52-week high of $32.72 after the company reported the emergency investigational NDA for brincidofovir authorized by the FDA. CareFusion CFN shares gained 23.13% to touch a new 52-week high of $56.85 after Becton Dickinson & Co BDX announced its plans to acquire CareFusion for $12.2 billion in cash and stock. Becton, Dickinson and Company BDX shares rose 6.47% to reach a new 52-week high of $123.34 on announcement of CareFusion acquisition.